Issledovaniâ i Praktika v Medicine (Mar 2016)

CLINICAL SIGNIFICANCE OF BIOMARKERS IN OVARIAN CANCER, PROSTATE CANCER, COLORECTAL CANCER

  • N. V. Marshutina,
  • M. P. Solokhina,
  • I. I. Alentov,
  • N. S. Sergeeva

DOI
https://doi.org/10.17709/2409-2231-2016-3-1-7
Journal volume & issue
Vol. 3, no. 1
pp. 46 – 57

Abstract

Read online

The review is devoted to modern notions about serum tumor markers and their place in oncology: using for differential diagnosis, in prognosis of course of tumor process, during follow-up, for preclinical detection of disease recurrences, as well as in screening aimed at early detection of malignant neoplasms. Algorithms of using of most informative tumor markers: CA125, HE4 (in ovarian cancer), PSA and its isoforms (in prostate cancer), iFOBT (in colorectal cancer) were described.

Keywords